 |
Poster communications
SIRPα blockade reinvigorates myeloid cells in the tumor microenvironment and reverses T-cell exclusion
Vanessa Gauttier
1
Justine Durand
1
Sabrina Pengam
1
Kevin Biteau
2, 3
Mélanie Neel
2, 3
Sophie Conchon
2, 3
Dominique Costantini
1
Bernard Vanhove
2, 3, 1
Nicolas Poirier
1
Mélanie Neel 2, 3
Author
Sophie Conchon 2, 3
Author
Dominique Costantini 1
Author
Bernard Vanhove 2, 3, 1
Author
Nicolas Poirier 1
Author
1
OSE Immunotherapeutics [Nantes, France] (France)
2
U1064 Inserm - CRTI - Centre de Recherche en Transplantation et Immunologie (CHU Nantes - Hôtel Dieu - 30 Bd Jean Monnet 44093 Nantes Cedex 01. - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U1064 (101, rue de Tolbiac, 75013 Paris - France)
- UFR MEDECINE - Université de Nantes - UFR de Médecine et des Techniques Médicales (1 rue Gaston Veil BP 53508 44035 NANTES Cedex 1 - France)
- UN - Université de Nantes (1, quai de Tourville - BP 13522 - 44035 Nantes cedex 1 - France)
3
ITUN - Institut de transplantation urologie-néphrologie (France)
- UN - Université de Nantes (1, quai de Tourville - BP 13522 - 44035 Nantes cedex 1 - France)
- CHU Nantes - Centre hospitalier universitaire de Nantes (1 Place Alexis-Ricordeau, 44000 Nantes - France)
Document type :
Poster communications
Domain :
Complete list of metadata
https://www.hal.inserm.fr/inserm-02159790
Contributor : Sylvie Le Bihan <>
Submitted on : Wednesday, June 19, 2019 - 8:56:21 AM
Last modification on : Friday, August 2, 2019 - 11:33:47 AM
Contributor : Sylvie Le Bihan <>
Submitted on : Wednesday, June 19, 2019 - 8:56:21 AM
Last modification on : Friday, August 2, 2019 - 11:33:47 AM
File
Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamaisPlease log in to resquest access to the document
Identifiers
- HAL Id : inserm-02159790, version 1
Collections
INSERM | UNIV-NANTES | CRTI
Citation
Vanessa Gauttier, Justine Durand, Sabrina Pengam, Kevin Biteau, Mélanie Neel, et al.. SIRPα blockade reinvigorates myeloid cells in the tumor microenvironment and reverses T-cell exclusion. AACR (American Association of Cancer Research), Mar 2019, Atlanta, United States. ⟨inserm-02159790⟩
Metrics
Record views